123 related articles for article (PubMed ID: 26462349)
1. [EXPRESSION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-κB LIGAND IN PERIPHERAL BLOOD OF PATIENTS WITH ASEPTIC LOOSENING OF THE IMPLANT AFTER TOTAL HIP APTHROPLASTY].
Hou K; Wang Y; Lu X; Yang K; Kong W; Li Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):853-6. PubMed ID: 26462349
[TBL] [Abstract][Full Text] [Related]
2. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V
Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
[TBL] [Abstract][Full Text] [Related]
4. The role of RANKL/RANK/OPG system in the canine model of hip periprosthetic infection osteolysis.
Zhang HW; Peng L; Li WB; Song KG
Int J Artif Organs; 2017 Feb; 39(12):619-624. PubMed ID: 28127738
[TBL] [Abstract][Full Text] [Related]
5. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin.
Crotti TN; Smith MD; Findlay DM; Zreiqat H; Ahern MJ; Weedon H; Hatzinikolous G; Capone M; Holding C; Haynes DR
Biomaterials; 2004 Feb; 25(4):565-73. PubMed ID: 14607494
[TBL] [Abstract][Full Text] [Related]
6. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
[TBL] [Abstract][Full Text] [Related]
7. Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.
Wang L; Dai Z; Xie J; Liao H; Lv C; Hu Y
Inflammation; 2016 Feb; 39(1):218-227. PubMed ID: 26294373
[TBL] [Abstract][Full Text] [Related]
8. Alendronate stimulates osteoprotegerin expression in fibroblasts from periprosthetic membrane.
Qian Y; Zhang XL; Jiang Y; Zeng BF; Wang Q; Chen Y; Shen H; Wang Q
Hip Int; 2015; 25(6):581-4. PubMed ID: 26351115
[TBL] [Abstract][Full Text] [Related]
9. Periprosthetic osteolysis and its association with RANKL expression.
Veigl D; Niederlová J; Kryštůfková O
Physiol Res; 2007; 56(4):455-462. PubMed ID: 16925460
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of aseptic loosening by receptor activator of nuclear factor kappa B ligand antibody in osteolysis model of mouse].
Zhao S; Cheng T; Peng X; Zhang X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):656-60. PubMed ID: 21735775
[TBL] [Abstract][Full Text] [Related]
11. Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures.
Galeone A; Brunetti G; Rotunno C; Oranger A; Colucci S; de Luca Tupputi Schinosa L; Zallone A; Grano M; Paparella D
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e141-7. PubMed ID: 23671202
[TBL] [Abstract][Full Text] [Related]
12. Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty.
He T; Wu W; Huang Y; Zhang X; Tang T; Dai K
Int Orthop; 2013 Jun; 37(6):1025-31. PubMed ID: 23467893
[TBL] [Abstract][Full Text] [Related]
13. [VASCULARITY STUDY ON PERIPROSTHETIC TISSUES AROUND ASEPTIC LOOSENING AFTER TOTAL HIP ARTHROPLASTY].
Wu W; Yan M; Zhu Z; Dai K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Jan; 30(1):39-43. PubMed ID: 27062844
[TBL] [Abstract][Full Text] [Related]
14. Genetic susceptibility to hip arthroplasty failure--association with the RANK/OPG pathway.
Malik MH; Bayat A; Jury F; Ollier WE; Kay PR
Int Orthop; 2006 Jun; 30(3):177-81. PubMed ID: 16583245
[TBL] [Abstract][Full Text] [Related]
15. Nano-sized Al
Li D; Wang C; Li Z; Wang H; He J; Zhu J; Zhang Y; Shen C; Xiao F; Gao Y; Zhang X; Li Y; Wang P; Peng J; Cai G; Zuo B; Yang Y; Shen Y; Song W; Zhang X; Shen L; Chen X
Cell Death Dis; 2018 Aug; 9(8):840. PubMed ID: 30082761
[TBL] [Abstract][Full Text] [Related]
16. The biology of aseptic osteolysis.
Holt G; Murnaghan C; Reilly J; Meek RM
Clin Orthop Relat Res; 2007 Jul; 460():240-52. PubMed ID: 17620815
[TBL] [Abstract][Full Text] [Related]
17. Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
Ma G; Ainola M; Liljeström M; Santavirta S; Poduval P; Zhao D; Chen T; Konttinen YT
J Rheumatol; 2005 Oct; 32(10):1943-50. PubMed ID: 16206351
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of p38 MAPK inhibitor on wear debris-induced inflammatory osteolysis through downregulating RANK/RANKL in a mouse model.
Chen D; Li Y; Guo F; Lu Z; Hei C; Li P; Jin Q
Genet Mol Res; 2015 Jan; 14(1):40-52. PubMed ID: 25729934
[TBL] [Abstract][Full Text] [Related]
19. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
20. MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model.
Chen D; Zhang X; Guo Y; Shi S; Mao X; Pan X; Cheng T
Int J Mol Med; 2012 Dec; 30(6):1417-23. PubMed ID: 23027468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
